The abstract is read at the publisher; the summary is JClub's.
Targeted Col4a1 deletion in adult mouse brain microvessels generates numerous cerebral microbleeds within 3 months, with dose-dependent accumulation over 6 months.
- Why it matters: Cerebral small vessel disease and its imaging biomarker, cerebral microbleeds, lack mechanistic animal models that reproduce human-like microbleed development.
- What they did: Eight-week-old Cas9 transgenic mice received retro-orbital AAV-BR1/CRISPR targeting Col4a1 or control Rosa26, followed for 6 months by behavioural testing, T2*-weighted MRI, histology, and electron microscopy.
- The result: Col4a1-depleted microvessels showed basement membrane thinning and haemosiderin deposits matching MRI CMBs, alongside progressive cognitive and motor deficits; in 836 human biobank participants, TIMP2 variants were linked to higher CMB burden (odds ratios 1.50–1.96).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.